Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Pharmaceutical and Nutraceutical Therapies for Liver Disease.

The Veterinary clinics of North America. Equine practice·2026
Same author

Fecal microbiota transplant for treatment of diarrhea in adult hospitalized horses-111 cases (2013-2018).

Open veterinary journal·2023
Same author

Factors Affecting Survival and Future Foaling Rates in Thoroughbred Mares with Hydrops.

Journal of equine veterinary science·2022
Same author

Symmetric dimethylarginine concentrations in healthy neonatal foals and mares.

Journal of veterinary internal medicine·2021
Same author

Point-of-Care Diagnostics in Equine Practice.

The Veterinary clinics of North America. Equine practice·2020
Same author

Equine platelet concentrate preparation and validation.

Journal of veterinary internal medicine·2019

Related Experiment Video

Updated: Jun 25, 2025

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI
07:31

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI

Published on: November 1, 2014

12.4K

Immune-mediated Equine Vasculopathies.

Rana Bozorgmanesh1

  • 1UC Davis, UC Davis Veterinary Medical Teaching Hospital, Large Animal Clinic, 1 Garrod Drive, Davis, CA 95616, USA.

The Veterinary Clinics of North America. Equine Practice
|May 24, 2024
PubMed
Summary
This summary is machine-generated.

Immune-mediated vasculopathies in horses, though rare, can cause significant illness. Triggers range from infections to auto-antigens, requiring diagnosis and treatment focused on cause removal and immunosuppression.

Keywords:
ArteritisImmune-mediated vasculopathyPurpura hemorrhagicaVasculitisVasculopathy

More Related Videos

Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups
10:35

Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups

Published on: January 12, 2020

8.6K
Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

7.7K

Related Experiment Videos

Last Updated: Jun 25, 2025

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI
07:31

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI

Published on: November 1, 2014

12.4K
Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups
10:35

Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups

Published on: January 12, 2020

8.6K
Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

7.7K

Area of Science:

  • Veterinary Immunology
  • Equine Pathology

Background:

  • Immune-mediated vasculopathies are conditions where the immune system attacks blood vessels.
  • Triggers include infections, foreign substances (viruses, drugs), and the body's own proteins.
  • These conditions, while uncommon in horses, can lead to serious illness.

Purpose of the Study:

  • To review immune-mediated vasculopathies in horses.
  • To outline potential causes, clinical signs, diagnosis, and treatment strategies.

Main Methods:

  • This review synthesizes information on equine immune-mediated vasculopathies.
  • Diagnostic approaches include presumptive diagnosis and histopathology of skin biopsies.
  • Treatment involves identifying and removing the trigger, immunosuppression, and supportive care.

Main Results:

  • Variable clinical signs depend on the severity and affected organs.
  • Examples of immune-mediated vasculopathies in horses include purpura hemorrhagica and systemic lupus erythematosus.
  • Diagnosis can be challenging, often relying on clinical signs and biopsy findings.

Conclusions:

  • Prompt diagnosis and management are crucial for horses with immune-mediated vasculopathies.
  • Treatment strategies aim to control the immune response and support the horse's recovery.
  • Further research may elucidate specific triggers and improve therapeutic outcomes.